Atossa Therapeutics (ATOS) Non Operating Interest Expenses (2011 - 2015)
Atossa Therapeutics' Non Operating Interest Expenses was $1,784 in Q1 2015, up 138.2% from $749.00 a year earlier but down 86.7% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Non Operating Interest Expenses (2011 - 2015) Analysis & Trends
On a trailing twelve-month basis, Atossa Therapeutics' Non Operating Interest Expenses was $16,804 through Mar 31, 2015; for FY2014, it came in at $15,769.
- Non Operating Interest Expenses shows a three-year compound annual growth rate of -4.3% (FY2011 to FY2014).
- In earlier years, Non Operating Interest Expenses was $360.00 in FY2013 (-97.0%), $12,040 in FY2012 (-33.1%) and $17,992 in FY2011.
- Quarterly Non Operating Interest Expenses has moved between $1.00 (Q3 2013) and $13,426 (Q4 2014) over five years.
- Compared with a year earlier, Non Operating Interest Expenses was higher in two of the last four quarters, with growth averaging 65.6%.
- Per Business Quant data, ATOS's Non Operating Interest Expenses in the three quarters before Q1 2015 was $13,426 (Q4 2014), $151.00 (Q3 2014) and $1,443 (Q2 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2015 | 1,784.00 |
| Dec 31, 2014 | 13,426.00 |
| Sep 30, 2014 | 151.00 |
| Jun 30, 2014 | 1,443.00 |
| Mar 31, 2014 | 749.00 |
| Sep 30, 2013 | 1.00 |
| Jun 30, 2013 | 352.00 |
| Mar 31, 2013 | 7.00 |
| Dec 31, 2012 | 224.00 |
| Sep 30, 2012 | 7,756.00 |
| Jun 30, 2012 | 2,446.00 |
| Mar 31, 2012 | 1,613.00 |
| Dec 31, 2011 | 9,604.00 |
| Sep 30, 2011 | 758.00 |
API Access
Atossa Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();